Schedule 13G ownership disclosure

ADVERUM BIOTECHNOLOGIES INC

Common Stock, $0.0001 par value per share · CUSIP: 00773U207

Event date: 2025-08-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Frazier Life Sciences Public Fund, L.P.

    Shares: 1,129,057.00 · Class: 5.4%

  • FHMLSP, L.P.

    Shares: 1,129,057.00 · Class: 5.4%

  • FHMLSP, L.L.C.

    Shares: 1,129,057.00 · Class: 5.4%

  • Frazier Life Sciences Public Overage Fund, L.P.

    Shares: 427,500.00 · Class: 2.0%

  • FHMLSP Overage, L.P.

    Shares: 427,500.00 · Class: 2.0%

  • FHMLSP Overage, L.L.C.

    Shares: 427,500.00 · Class: 2.0%

  • Frazier Life Sciences X, L.P.

    Shares: 129,870.00 · Class: 0.6%

  • FHMLS X, L.P.

    Shares: 129,870.00 · Class: 0.6%

  • FHMLS X, L.L.C.

    Shares: 129,870.00 · Class: 0.6%

  • Frazier Life Sciences XI, L.P.

    Shares: 272,945.00 · Class: 1.3%

  • FHMLS XI, L.P.

    Shares: 272,945.00 · Class: 1.3%

  • FHMLS XI, L.L.C.

    Shares: 272,945.00 · Class: 1.3%

  • Frazier Life Sciences XII, L.P.

    Shares: 118,059.00 · Class: 0.6%

  • FHMLS XII, L.P.

    Shares: 118,059.00 · Class: 0.6%

  • FHMLS XII, L.L.C.

    Shares: 118,059.00 · Class: 0.6%

  • James N. Topper

    Shares: 129,870.00 · Class: 0.6%

  • Patrick J. Heron

    Shares: 129,870.00 · Class: 0.6%

  • Albert Cha

    Shares: 0.00 · Class: 0.0%

  • James Brush

    Shares: 0.00 · Class: 0.0%

  • Daniel Estes

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-021779
Form type
SCHEDULE 13G/A
Filer
Adverum Biotechnologies, Inc.
CIK
CIK 1501756
Filed
Aug 14, 2025
Reporting period
Aug 12, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub